Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study. - Wikidata - wikimedia - TriplyDB

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.

http://www.wikidata.org/entity/Q37674134

about

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency.

P2860

Q54985540-2287B4A4-8FDC-4AE3-AED6-12AE54C555D6

P2860

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.

http://www.wikidata.org/entity/Q37674134

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fatty liver associated with me ...... d attenuation parameter study.

@en

Fatty liver associated with me ...... d attenuation parameter study.

@nl

type

label

Fatty liver associated with me ...... d attenuation parameter study.

@en

Fatty liver associated with me ...... d attenuation parameter study.

@nl

prefLabel

Fatty liver associated with me ...... d attenuation parameter study.

@en

Fatty liver associated with me ...... d attenuation parameter study.

@nl

P1433

Q37674134-3B8548D1-0EBB-4E78-A6B7-3804033D7E63

P1476

Q37674134-EFC61748-CCDB-4A4F-BC37-0F54EDA25299

P2093

Q37674134-0A026FCE-25E6-4EE5-95EE-DDDE11047BDA

Q37674134-1CBE2B09-A641-4CCE-A953-2CA6F496E5FA

Q37674134-1D555A52-50EA-4AF1-BCEF-5BB4277EE45C

Q37674134-2BA9DEF1-1140-46DA-9656-A118364C8CFD

Q37674134-4182B431-55D4-4DCE-BC29-D0018A9D9836

Q37674134-42056CEA-E3B0-4E3E-A407-C0BA60601E23

Q37674134-449538BB-7FE3-4F16-A724-AD735D14E791

Q37674134-6B2B02E3-0B02-4139-A28C-F01332A8A803

Q37674134-6BCE2CA7-31BE-4645-9038-3DB7F45CB510

Q37674134-7F87AAE2-A7F8-4DF2-9B9C-686D796ED5B5

P2860

Q37674134-04C86D15-CB28-422D-9574-8080EE35111A

Q37674134-0AAA4163-325D-4393-8BFA-6E455CB6ECBD

Q37674134-0B7032A7-F3DA-4B46-8BC0-D9E8D88E023F

Q37674134-0EAD0DDA-E070-4295-BB5B-CA381B2E82DD

Q37674134-106074AE-D5BB-4B39-AC30-FD0A4D50B58D

Q37674134-18B6ADE2-5DBD-4AD0-B48E-B75D328A1489

Q37674134-1FD6082A-BC41-4A24-B1AF-92CBF2327207

Q37674134-2B1B9C27-0946-4F0F-B8EA-4F20A4752DE3

Q37674134-36D67E35-DCA0-4B8D-B0CB-31E7EFC209E4

Q37674134-37096EEE-A012-4698-AE32-6247EA6F1FC6

P304

Q37674134-8CE96883-7034-4D31-AF2C-A51FAEC3A655

P31

Q37674134-E1DEC9C0-85F0-48F4-905D-4B0E2B1989C9

P356

Q37674134-2DC5C0DF-6EAB-42F8-9511-5C295BDB4465

P433

Q37674134-BFCA8694-7BC8-4224-A626-35366A3CCA59

P478

Q37674134-DA4166A8-7C9D-4046-AB96-325F3A38A217

P50

Q37674134-3621FF5C-BEBD-4ACA-AD03-1530E41BA501

Q37674134-7DF37920-A77E-437C-8490-C538B9119FCA

Q37674134-B82C8D75-1D1E-4F0D-93C6-626F811B1F85

Q37674134-BF4E7D27-241F-4510-9504-7E4D29201442

P577

Q37674134-E0CE5003-78AF-40C6-85F1-CFA08CFC5004

P698

Q37674134-4108E2E9-1F81-4CC9-8FD4-88BABC97057B

P932

Q37674134-7B7C665F-BA30-424E-84CA-6D96A4C06C6C

P356

J.KRCP.2017.36.1.48

P1433

Kidney research and clinical practice

P1476

Fatty liver associated with me ...... d attenuation parameter study.

@en

P2093

Chang-Yun Yoon

http://www.w3.org/2001/XMLSchema#string

Hyunsun Lim

http://www.w3.org/2001/XMLSchema#string

In Mee Han

http://www.w3.org/2001/XMLSchema#string

Jung Tak Park

http://www.w3.org/2001/XMLSchema#string

Kyoung Sook Park

http://www.w3.org/2001/XMLSchema#string

Mi Jung Lee

http://www.w3.org/2001/XMLSchema#string

Misol Lee

http://www.w3.org/2001/XMLSchema#string

Seung Gyu Han

http://www.w3.org/2001/XMLSchema#string

Seung Hyeok Han

http://www.w3.org/2001/XMLSchema#string

Tae Ik Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity, Metabolic Syndrome, and Cardiovascular Disease

A new equation to estimate glomerular filtration rate

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

P304

48-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.23876/J.KRCP.2017.36.1.48

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28392997

http://www.w3.org/2001/XMLSchema#string

P932

5331975

http://www.w3.org/2001/XMLSchema#string